Clinical Trial Radar Terms & Policy

Terms of Use

Please review the Clinical Trial Radar ("Trial Radar") Beta Participation Terms of Use.


Trial Radar provides access to information about clinical trials primarily sourced from, which is maintained by the National Library of Medicine (NLM). Please refer to these Terms and Conditions for use of data.

Privacy Policy

This Privacy Policy outlines how the Clinical Trials Discovery Tool ("Trial Radar") safeguards user data. Operating under Investment Strategy, Inc., incorporated in Delaware and registered in California, Trial Radar is committed to protecting your privacy and complying with applicable data protection laws.

Your Data and Privacy

  1. Data Collection and Use: Trial Radar does not collect or store personal health information. User inputs are utilized to provide general clinical trial information without linking to individual health records.
  2. Generalized Clinical Trial Information: The tool offers non-personalized, general information about clinical trials.
  3. Not a Medical Advice Substitute: Trial Radar is not a substitute for professional medical advice. Consult healthcare professionals for medical-related inquiries.
  4. Legal Disclaimer: Users agree to not hold Trial Radar, its developers, or affiliates liable for any privacy breaches or claims arising from its use. The tool is offered "as is" without warranties, and usage is at your own risk.

User Anonymity and Data Security

While Trial Radar ensures user anonymity in general usage, the "Alerts" feature requires users to provide an email address to receive notifications. This section explains how we handle and protect your email information.

Legal Compliance and Updates

We regularly update our policy to remain compliant.

By using Trial Radar, you acknowledge and agree to these Terms and the Privacy Policy, and to the Terms and Conditions for use of data. If you disagree, refrain from using the tool. Continued usage implies acceptance of any modifications. We encourage regular review of this policy for updates.

Last updated: Dec 31, 2023